← Back to Search

Partial Chest Wall Radiation Therapy for Breast Cancer

Phase < 1
Waitlist Available
Led By Alexander Stessin, MD PhD
Research Sponsored by Stony Brook University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if targeting radiation only to the area where cancer cells were found after breast surgery is as effective as radiating the entire chest wall. The goal is to see if this focused approach can reduce the risk of cancer returning while avoiding unnecessary treatment. This could benefit breast cancer patients by minimizing side effects and overtreatment.

Eligible Conditions
  • Ductal Carcinoma
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acute toxicity
Breast cancer recurrence
Delayed toxicity
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Radiation TreatmentExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Stony Brook UniversityLead Sponsor
222 Previous Clinical Trials
42,031 Total Patients Enrolled
5 Trials studying Breast Cancer
287 Patients Enrolled for Breast Cancer
Alexander Stessin, MD PhDPrincipal InvestigatorStony Brook University

Media Library

Partial Chest Wall Radiation Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05436808 — Phase < 1
Breast Cancer Research Study Groups: Radiation Treatment
Breast Cancer Clinical Trial 2023: Partial Chest Wall Radiation Therapy Highlights & Side Effects. Trial Name: NCT05436808 — Phase < 1
Partial Chest Wall Radiation Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05436808 — Phase < 1
~0 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top